CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

被引：0
|
作者：
Chavaz, Lara [1 ]
Royston, Lena [1 ]
Masouridi-Levrat, Stavroula [1 ]
Mamez, Anne-Claire [1 ]
Giannotti, Federica [1 ]
Morin, Sarah [1 ]
Van Delden, Christian [1 ]
Chalandon, Yves [1 ]
Neofytos, Dionysios [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O102
引用
下载
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review
    Sepassi, Aryana
    Saunders, Ila M.
    Bounthavong, Mark
    Taplitz, Randy A.
    Logan, Cathy
    Watanabe, Jonathan H.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (04) : 1138 - 1149
  • [22] Cmv Specific Cellmediated Immune Reconstitution During Letermovir Prophylaxis in High Risk Hematopoietic Cell Transplant Recipients
    Abidi, M.
    Gutman, J.
    Weinberg, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 408 - 408
  • [23] Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation
    Bashey, Saffiya Z.
    Solomon, Scott R.
    Zhang, Xu
    Morris, Lawrence E.
    Holland, H. Kent
    Bachier, Lizamarie
    Solh, Melhem M.
    BONE MARROW TRANSPLANTATION, 2024, 59 (04) : 564 - 565
  • [24] Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation
    Saffiya Z. Bashey
    Scott R. Solomon
    Xu Zhang
    Lawrence E. Morris
    H. Kent Holland
    Lizamarie Bachier
    Melhem M. Solh
    Bone Marrow Transplantation, 2024, 59 : 564 - 565
  • [25] Incidence of CMV replication and the role of letermovir primary/secondary prophylaxis in the early phase after allogeneic hematopoietic stem cell transplantation
    Studer, U.
    Medinger, M.
    Khanna, N.
    Leuzinger, K.
    Hirsch, H.
    Heim, D.
    Lengerke, C.
    Tsakiris, D.
    Halter, J.
    Gerull, S.
    Passweg, J.
    Gwerder, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 198 - 199
  • [26] Additional Evidence for the Efficacy of Letermovir in the Prophylaxis of CMV Reactivation and Disease in Adults after allogeneic HSCT
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2022, 49 (04) : 269 - 269
  • [27] Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era
    Sassine, Joseph
    Khawaja, Fareed
    Shigle, Terri Lynn
    Handy, Victoria
    Foolad, Farnaz
    Aitken, Samuel L.
    Jiang, Ying
    Champlin, Richard
    Shpall, Elizabeth
    Rezvani, Katy
    Ariza-Heredia, Ella J.
    Chemaly, Roy F.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (08) : 1346 - 1354
  • [28] Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation
    Takenaka, Katsuto
    Fuji, Shigeo
    Matsukawa, Toshihiro
    Uchida, Naoyuki
    Kobayashi, Takeshi
    Tanaka, Masatsugu
    Ara, Takahide
    Ikegame, Kazuhiro
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Sawa, Masashi
    Maruyama, Yumiko
    Fukuda, Takahiro
    Nakamae, Hirohisa
    Kimura, Takafumi
    Ogata, Masao
    Seo, Sachiko
    Atsuta, Yoshiko
    Matsuo, Keitaro
    Nakasone, Hideki
    BLOOD, 2023, 142
  • [29] Letermovir Primary Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: Real-Life Data from a University Hospital in Argentina
    Herrera, Fabian
    Torres, Diego
    Querci, Marcia
    Rearte, Andres Nicolas
    Temporiti, Elena
    Riera, Leandro
    Duarte, Patricio
    Videla, Cristina
    Bonvehi, Pablo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [30] EFFECTIVENESS OF LETERMOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN SEROPOSITIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A GLOBAL SYSTEMATIC REVIEW
    Sepassi, A.
    Saunders, I
    Bounthavong, M.
    Watanabe, J.
    VALUE IN HEALTH, 2022, 25 (07) : S322 - S322
12345